Overview

Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO)

Status:
Completed

Trial end date:
2020-06-10

Target enrollment:

Participant gender:

Summary

The primary objective of this study is to evaluate the efficacy of topical MOB015B in patients with mild to moderate distal subungual onychomycosis (DSO). The secondary objective is to evaluate the safety of topical MOB015B in patients with mild to moderate DSO.

Phase:

Phase 3

Details

Lead Sponsor:

Moberg Pharma AB

Treatments:

Ciclopirox